The revised agreement arrived after the legal meeting had been postponed by one day, with the data-sale clause crossed out.
Elin Vale’s cover message said the network accepted the clinic’s general approach, subject to field reports, independent oversight, and medical screening for participating team members. The network could review the protocols for safety. It would not obtain exclusive ownership of the clinic’s work or sell patient data under the sponsorship.
The network attached a reduced supply budget after its commercial office withdrew the proposed data-sale revenue. It covered the trial medical kit and screening but left the clinic’s planned second afternoon supply order unfunded. Tessa called Leah before the meeting; they agreed to keep that afternoon referral-only until another source was confirmed. No one would promise patients supplies the clinic did not have.
Tessa read the changes with Nora before calling the others. The draft separated general procedures from identifiable records and optional research. A field report could describe hazards, equipment failures, and treatment outcomes in general terms. It could not include patient-identifying information unless a separate authorization applied.
“What does ‘outcome’ mean here?” Tessa asked.
Nora marked the definition. “It could be useful for safety, but the wording should prevent a detailed account from identifying someone indirectly.”
